What development phase is Cifenline in?

Cifenline is FDA-approved (marketed).

What is the generic name of Cifenline?

cibenzoline is the generic (nonproprietary) name of Cifenline.

Last reviewed 2026-04-20 · How we verify

Cifenline (cibenzoline)

FDA-approved active Quality 19/100

At a glance

Generic name	cibenzoline
Drug class	cibenzoline
Target	ATP-sensitive inward rectifier potassium channel 11, Potassium voltage-gated channel subfamily H member 2, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Therapeutic area	Cardiovascular
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation (PHASE4)
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cifenline CI brief — competitive landscape report
Cifenline updates RSS · CI watch RSS
portfolio CI